TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
GLSI

Greenwich Lifesciences Inc

Healthcare · Biotechnology

17.50$ +0.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GLSI
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
0.2% 78.4% 25.6% 99.9% 100.0% 99.9% 99.9% 100.0% 100.0%
0.2% 78.4% 25.6% 99.9% 100.0% 99.9% 99.9% 100.0% 100.0%
0.2% 78.4% 25.6% 99.9% 100.0% 99.9% 99.9% 100.0% 100.0%
– 21.6% 74.4% 0.1% 0.0% 0.1% 0.1% 0.0% –
31,572.8% 9,423.4% 5,163.2% 3.6% 1.4% 2.0% 4.2% 77.8% 94.3%
2,056.9% 671.2% 5,163.2% 3.6% 1.4% 2.0% 4.2% 77.8% 94.3%
– – 2,381.4% 1.0% – – – – –
594.5% 255.7% 2,738.2% 2.5% 0.8% 1.6% 0.5% 68.5% 78.9%
-31,472.8% -9,323.4% -5,063.2% 96.4% 98.6% 98.0% 95.8% 22.2% 5.7%
-81,534.2% -21,916.0% -102,035.9% -101.4% -123.6% -307.7% -720.0% -1,655.7% -1,410.4%
43,327.8% 11,027.9% 44,031.2% 44.3% 47.6% 95.8% 183.7% 317.9% 219.1%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?